Evaluation of potential immunity against the novel severe acute respiratory syndrome (SARS) coronavirus that emerged in 2019 (SARS-CoV-2) is essential for health, as well as social and economic recovery. Generation of antibody response to SARS-CoV-2 (seroconversion) may inform on acquired immunity from prior exposure, and antibodies against the SARS-CoV-2 spike protein receptor binding domain (S-RBD) are speculated to neutralize virus infection. Some serology assays rely solely on SARS-CoV-2 nucleocapsid protein (N-protein) as the antibody detection antigen; however, whether such immune responses correlate with S-RBD response and COVID-19 immunity remains unknown. Here, we generated a quantitative serological ELISA using recombinant S-RBD and N-protein for the detection of circulating antibodies in 138 serial serum samples from 30 reverse transcription PCR–confirmed, SARS-CoV-2–hospitalized patients, as well as 464 healthy and non–COVID-19 serum samples that were collected between June 2017 and June 2020. Quantitative detection of IgG antibodies against the 2 different viral proteins showed a moderate correlation. Antibodies against N-protein were detected at a rate of 3.6% in healthy and non–COVID-19 sera collected during the pandemic in 2020, whereas 1.9% of these sera were positive for S-RBD. Approximately 86% of individuals positive for S-RBD–binding antibodies exhibited neutralizing capacity, but only 74% of N-protein–positive individuals exhibited neutralizing capacity. Collectively, our studies show that detection of N-protein–binding antibodies does not always correlate with presence of S-RBD–neutralizing antibodies and caution against the extensive use of N-protein–based serology testing for determination of potential COVID-19 immunity.
Kathleen M. McAndrews, Dara P. Dowlatshahi, Jianli Dai, Lisa M. Becker, Janine Hensel, Laura M. Snowden, Jennifer M. Leveille, Michael R. Brunner, Kylie W. Holden, Nikolas S. Hopkins, Alexandria M. Harris, Jerusha Kumpati, Michael A. Whitt, J. Jack Lee, Luis L. Ostrosky-Zeichner, Ramesha Papanna, Valerie S. LeBleu, James P. Allison, Raghu Kalluri
Title and authors | Publication | Year |
---|---|---|
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E. Shapiro, Victoria L. Campbell, Christopher L. McClurkan, Lichen Jing, Robin Gross, Janie Liang, Elena Postnikova, Steven Mazur, Vladimir V. Lukin, Anu Chaudhary, Marie K. Das, Susan L. Fink, Andrew Bryan, Alexander L. Greninger, Keith R. Jerome, Michael R. Holbrook, Terry B. Gernsheimer, Mark H. Wener, Anna Wald, David M. Koelle |
Journal of Clinical Investigation | 2021 |
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Y Galipeau, V Siragam, G Laroche, E Marion, M Greig, M McGuinty, RA Booth, Y Durocher, M Cuperlovic-Culf, SA Bennett, AM Crawley, PM Giguère, C Cooper, MA Langlois |
EBioMedicine | 2021 |
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
DM Smadja, SJ Mentzer, M Fontenay, MA Laffan, M Ackermann, J Helms, D Jonigk, R Chocron, GB Pier, N Gendron, S Pons, JL Diehl, C Margadant, C Guerin, EJ Huijbers, A Philippe, N Chapuis, P Nowak-Sliwinska, C Karagiannidis, O Sanchez, P Kümpers, D Skurnik, AM Randi, AW Griffioen |
Angiogenesis | 2021 |
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation
S Kang, M Yang, S He, Y Wang, X Chen, YQ Chen, Z Hong, J Liu, G Jiang, Q Chen, Z Zhou, Z Zhou, Z Huang, , H He, W Zheng, HX Liao, F Xiao, H Shan, S Chen |
Nature Communications | 2021 |
Immune response variables and viral mutations impact on COVID-19 reinfection and relapse
S Sanaie, E Golipour, A Shamekh, MR Sadaie, A Mahmoodpoor, M Yousefi |
International Immunopharmacology | 2021 |
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients
T Schwarz, K Heiss, Y Mahendran, F Casilag, F Kurth, LE Sander, CM Wendtner, MA Hoechstetter, MA Müller, R Sekul, C Drosten, V Stadler, VM Corman |
Frontiers in immunology | 2021 |
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
KA Eberhardt, F Dewald, E Heger, L Gieselmann, K Vanshylla, M Wirtz, F Kleipass, W Johannis, P Schommers, H Gruell, KA Brensing, RU Müller, M Augustin, C Lehmann, M Koch, F Klein, VD Cristanziano |
Microorganisms | 2021 |
Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA
M Dileepan, D Di, Q Huang, S Ahmed, D Heinrich, H Ly, Y Liang |
Virulence | 2021 |
Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area
S Jain, K Garg, SM Tran, IL Rask, M Tarczon, V Nandi, DA Kessler, D Strauss, BS Sachais, K Yazdanbakhsh, S Rehmani, L Luchsinger, PA Shi |
Transfusion | 2021 |
Use of Quantitative Dried Blood Spots to Evaluate the Post-Vaccination Level of Neutralizing Antibodies against SARS-CoV-2
A Marchand, I Roulland, F Semence, O Beck, M Ericsson |
Life Sciences | 2021 |
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
MV Murhekar, T Bhatnagar, JW Thangaraj, V Saravanakumar, MS Kumar, S Selvaraju, K Rade, CP Kumar, R Sabarinathan, A Turuk, S Asthana, R Balachandar, SD Bangar, AK Bansal, V Chopra, D Das, AK Deb, KR Devi, V Dhikav, GR Dwivedi, SM Khan, MS Kumar, A Laxmaiah, M Madhukar, A Mahapatra, C Rangaraju, J Turuk, R Yadav, R Andhalkar, K Arunraj, DK Bharadwaj, P Bharti, D Bhattacharya, J Bhat, AS Chahal, D Chakraborty, A Chaudhury, H Deval, S Dhatrak, R Dayal, D Elantamilan, P Giridharan, I Haq, RK Hudda, B Jagjeevan, A Kalliath, S Kanungo, NN Krishnan, JS Kshatri, A Kumar, N Kumar, VG Kumar, GG Lakshmi, G Mehta, NK Mishra, A Mitra, K Nagbhushanam, A Nimmathota, AR Nirmala, AK Pandey, GV Prasad, MA Qurieshi, SD Reddy, A Robinson, S Sahay, R Saxena, K Sekar, VK Shukla, HB Singh, PK Singh, P Singh, R Singh, N Srinivasan, DS Varma, A Viramgami, VC Wilson, S Yadav, S Yadav, K Zaman, A Chakrabarti, A Das, RS Dhaliwal, S Dutta, R Kant, AM Khan, K Narain, S Narasimhaiah, C Padmapriyadarshini, K Pandey, S Pati, S Patil, H Rajkumar, T Ramarao, YK Sharma, S Singh, S Panda, DC Reddy, B Bhargava, T Anand, GR Babu, H Chauhan, T Dikid, RR Gangakhedkar, S Kant, S Kulkarni, JP Muliyil, RM Pandey, S Sarkar, N Shah, A Shrivastava, SK Singh, S Zodpe, A Hindupur, PR Asish, M Chellakumar, D Chokkalingam, S Dasgupta, MM Gowtham, A Jose, K Kalaiyarasi, NN Karthik, T Karunakaran, G Kiruthika, HD Kumar, SS Kumar, MP Kumar, E Michaelraj, J Pradhan, EB Prasath, DG Rachel, S Rani, A Rozario, R Sivakumar, PG Soundari, K Sujeetha, A Vinod |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
V Legros, S Denolly, M Vogrig, B Boson, E Siret, J Rigaill, S Pillet, F Grattard, S Gonzalo, P Verhoeven, O Allatif, P Berthelot, C Pélissier, G Thiery, E Botelho-Nevers, G Millet, J Morel, S Paul, T Walzer, FL Cosset, T Bourlet, B Pozzetto |
Cellular and Molecular Immunology | 2021 |
The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro
J Lyu, L Bao, X Shen, C Yan, C Zhang, W Wei, Y Yang, J Li, J Dong, L Xiao, X Zhou, Y Li |
International Immunopharmacology | 2021 |
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases
J Castillo-Olivares, DA Wells, M Ferrari, AC Chan, P Smith, A Nadesalingam, M Paloniemi, GW Carnell, L Ohlendorf, D Cantoni, M Mayora-Neto, P Palmer, P Tonks, NJ Temperton, D Peterhoff, P Neckermann, R Wagner, R Doffinger, S Kempster, AD Otter, A Semper, T Brooks, A Albecka, LC James, M Page, W Schwaeble, H Baxendale, JL Heeney |
Frontiers in immunology | 2021 |
An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization
N Wohlgemuth, K Whitt, S Cherry, EK Roubidoux, CY Lin, KJ Allison, A Gowen, P Freiden, EK Allen, AH Gaur, JH Estepp, L Tang, T Mori, DR Hijano, H Hakim, MA McGargill, F Krammer, MA Whitt, J Wolf, PG Thomas, S Schultz-Cherry, DR Perez |
Microbiology spectrum | 2021 |
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray
D Camerini, AZ Randall, K Trappl-Kimmons, A Oberai, C Hung, J Edgar, A Shandling, V Huynh, AA Teng, G Hermanson, JV Pablo, MM Stumpf, SN Lester, J Harcourt, A Tamin, M Rasheed, NJ Thornburg, PS Satheshkumar, X Liang, RB Kennedy, A Yee, M Townsend, JJ Campo, A Sinclair |
Microbiology spectrum | 2021 |
Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms
T Molnar, R Varnai, D Schranz, L Zavori, Z Peterfi, D Sipos, M Tőkés-Füzesi, Z Illes, A Buki, P Csecsei |
Journal of Clinical Medicine | 2021 |
Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
G Ireland, A Jeffery-Smith, M Zambon, K Hoschler, R Harris, J Poh, F Baawuah, J Beckmann, IO Okike, S Ahmad, J Garstang, AJ Brent, B Brent, F Aiano, Z Amin-Chowdhury, L Letley, SE Jones, M Kall, M Patel, R Gopal, R Borrow, E Linley, G Amirthalingam, KE Brown, ME Ramsay, SN Ladhani |
2021 | |
Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination
HN Grome, M Threlkeld, S Threlkeld, C Newman, RB Martines, S Reagan-Steiner, MA Whitt, M Gomes-Solecki, N Nair, MM Fill, TF Jones, W Schaffner, J Dunn |
Emerging infectious diseases | 2021 |
SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
J Fröberg, J Gillard, R Philipsen, K Lanke, J Rust, D van Tuijl, K Teelen, T Bousema, E Simonetti, CE van der Gaast-de Jongh, M Bos, FJ van Kuppeveld, BJ Bosch, M Nabuurs-Franssen, N van der Geest-Blankert, C van Daal, MA Huynen, MI de Jonge, DA Diavatopoulos |
Nature Communications | 2021 |
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
Y Wang, R Chen, F Hu, Y Lan, Z Yang, C Zhan, J Shi, X Deng, M Jiang, S Zhong, B Liao, K Deng, J Tang, L Guo, M Jiang, Q Fan, M Li, J Liu, Y Shi, X Deng, X Xiao, M Kang, Y Li, W Guan, Y Li, S Li, F Li, N Zhong, X Tang |
2021 | |
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
NY Pang, AS Pang, VT Chow, DY Wang |
Military Medical Research | 2021 |
SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic
AY Popova, VS Smirnov, EE Andreeva, EA Babura, SV Balakhonov, NS Bashketova, SA Bugorkova, MV Bulanov, NN Valeullina, VV Vetrov, DV Goryaev, TN Detkovskaya, EB Ezhlova, NN Zaitseva, OA Istorik, IV Kovalchuk, DN Kozlovskikh, SY Kombarova, OP Kurganova, AE Lomovtsev, LA Lukicheva, LV Lyalina, AA Melnikova, OM Mikailova, AK Noskov, LN Noskova, EE Oglezneva, TP Osmolovskaya, MA Patyashina, NA Penkovskaya, LV Samoilova, TF Stepanova, OE Trotsenko, AA Totolian |
Viruses | 2021 |
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
J Favresse, C Gillot, LD Chiaro, C Eucher, M Elsen, SV Eeckhoudt, C David, L Morimont, JM Dogné, J Douxfils |
Viruses | 2021 |
Enhancing the Stability of COVID‐19 Serological Assay through Metal–Organic Framework Encapsulation
Y Wang, Z Wang, P Gupta, JJ Morrissey, RR Naik, S Singamaneni |
Advanced Healthcare Materials | 2021 |
SARS‐CoV‐2 antibodies started to decline just four months after COVID‐19 infection in a paediatric population
A Breuer, A Raphael, H Stern, M Odeh, J Fiszlinski, N Algur, S Magen, O Megged, Y Schlesinger, Y BarakCorren, E Heiman |
Acta paediatrica (Oslo, Norway : 1992) | 2021 |
Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease
SF Brynjolfsson, H Sigurgrimsdottir, ED Einarsdottir, GA Bjornsdottir, B Armannsdottir, GE Baldvinsdottir, A Bjarnason, O Gudlaugsson, S Gudmundsson, ST Sigurdardottir, A Love, KG Kristinsson, BR Ludviksson |
Frontiers in immunology | 2021 |
Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test
JT Heggestad, DS Kinnamon, LB Olson, J Liu, G Kelly, SA Wall, S Oshabaheebwa, Z Quinn, CM Fontes, DY Joh, AM Hucknall, C Pieper, JG Anderson, IA Naqvi, L Chen, LG Que, T Oguin, SK Nair, BA Sullenger, CW Woods, TW Burke, GD Sempowski, BD Kraft, A Chilkoti |
Science Advances | 2021 |
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
A Deshpande, BD Harris, L Martinez-Sobrido, JJ Kobie, MR Walter |
Frontiers in immunology | 2021 |
Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
T Perkmann, T Koller, N Perkmann-Nagele, M Klausberger, M Duerkop, B Holzer, B Hartmann, P Mucher, A Radakovics, M Ozsvar-Kozma, OF Wagner, CJ Binder, H Haslacher, W Lainhart |
Microbiology spectrum | 2021 |
The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review
J Kulikowska, A Kulczyńska-Przybik, B Mroczko, A Kułakowska |
International journal of molecular sciences | 2021 |
Longitudinal detection of SARS‐CoV‐2‐specific antibody responses with different serological methods
P Emmerich, R Possel, CJ Hemmer, C Fritzsche, H GeerdesFenge, B Menge, C Messing, V BorchardtLohölter, C Deschermeier, K Steinhagen |
Journal of Medical Virology | 2021 |
A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States
D Alfego, A Sullivan, B Poirier, J Williams, A Grover, L Gillim, D Adcock, S Letovsky |
2021 | |
Post-vaccination cases of COVID-19 among healthcare workers at Siloam Teaching Hospital, Indonesia
C Cucunawangsih, RS Wijaya, NP Lugito, I Suriapranata |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings
DO Andrey, S Yerly, B Meyer, I Arm-Vernez, P Roux-Lombard, G Togni, I Guessous, H Spechbach, S Stringhini, T Agoritsas, J Stirnemann, JL Reny, CA Siegrist, I Eckerle, L Kaiser, N Vuilleumier |
Journal of Clinical Medicine | 2021 |
Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors
Z Szabó, T Szabó, K Bodó, G Kemenesi, F Földes, K Kristóf, E Barabás, B Vásárhelyi, Z Prohászka, E Fodor, F Jakab, T Berki, Z Lacza |
Practical Laboratory Medicine | 2021 |
Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients
M Hiki, Y Tabe, T Ai, Y Matsue, N Harada, K Sugimoto, Y Matsushita, M Matsushita, M Wakita, S Misawa, M Idei, T Miida, N Tamura, K Takahashi, T Naito, C Selvaraj |
PloS one | 2021 |
Diagnostic Value of IgM and IgG Detection in COVID-19 Diagnosis by the Mobile Laboratory B-LiFE: A Massive Testing Strategy in the Piedmont Region
O Nyabi, M Bentahir, J Ambroise, B Bearzatto, N Chibani, B Smits, JF Durant, A Vybornov, O Thellin, BE Moualij, JL Gala |
International journal of environmental research and public health | 2021 |
Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays
A Dörschug, H Frickmann, J Schwanbeck, E Yilmaz, K Mese, A Hahn, U Groß, AE Zautner |
Diagnostics | 2021 |
Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA
JS Schultz, MK McCarthy, C Rester, KR Sabourin, K Annen, M DomBourian, E Eisenmesser, A Frazer-Abel, V Knight, T Jaenisch, TE Morrison, R Rochford, RM Kedl, YW Tang |
Journal of clinical microbiology | 2021 |
Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China
X Feng, J Yin, J Zhang, Y Hu, Y Ouyang, S Qiao, H Zhao, T Zhang, X Li, L Zhang, J Zhang, R Jin, Y Feng, B Su |
Frontiers in immunology | 2021 |
Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests
P van Dam, M Huizing, E Roelant, A Hotterbeekx, FH Winter, S Kumar-Singh, P Moons, Z Amajoud, C Vulsteke, L Croes, A Janssens, Z Berneman, H Prenen, L Meuris, WV Berghe, E Smits, M Peeters |
European Journal of Cancer | 2021 |
Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali
J Woodford, I Sagara, A Dicko, A Zeguime, MB Doucoure, J Kwan, I Zaidi, J Doritchamou, M Snow-Smith, N Alani, J Renn, I Kosik, J Holly, J Yewdell, D Esposito, K Sadtler, P Duffy |
The Journal of Infectious Diseases | 2021 |
In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses
A Castro, K Ozturk, M Zanetti, H Carter, J Bhattacharya |
PloS one | 2021 |
Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
JM Capcha, G Lambert, DM Dykxhoorn, AG Salerno, JM Hare, MA Whitt, S Pahwa, DT Jayaweera, LA Shehadeh |
Frontiers in Cardiovascular Medicine | 2021 |
The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis
Y Fu, Y Pan, Z Li, Y Li |
Frontiers in microbiology | 2021 |
Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays
N Renard, S Daniel, N Cayet, M Pecquet, F Raymond, S Pons, J Lupo, C Tourneur, C Pretis, G Gerez, P Blasco, M Combe, I Canova, M Lesénéchal, F Berthier, YW Tang |
Journal of clinical microbiology | 2021 |
The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries
CE dos Santos Ferreira, H Gómez-Dantés, NC Bellei, E López, KA Crespo, M ORyan, J Villegas |
Viruses | 2021 |
Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples
A Szymczak, N Jędruchniewicz, A Torelli, A Kaczmarzyk-Radka, R Coluccio, M Kłak, A Konieczny, S Ferenc, W Witkiewicz, E Montomoli, P Miernikiewicz, R Bąchor, K Dąbrowska |
Journal of General Virology | 2021 |
Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina
B Šušak, V Mikulić, A Lazarević, I Mikulić, J Arapovic |
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences | 2021 |
Expression of SARS-CoV-2 surface glycoprotein fragment 319–640 in E. coli, and its refolding and purification
Fitzgerald GA, Komarov A, Kaznadzey A, Mazo I, Kireeva ML |
Protein Expression and Purification | 2021 |
Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications
Sun Z, Zheng X, Ji F, Zhou M, Su X, Ren K, Li L |
2021 | |
SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali.
Sagara I, Woodford J, Dicko A, Zeguime A, Doucoure M, Kwan J, Zaidi I, Doritchamou J, Snow-Smith M, Alani N, Renn J, Kosik I, Holly J, Yewdell J, Esposito D, Sadtler K, Duffy P |
medRxiv : the preprint server for health sciences | 2021 |